[RGLS] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
14-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -21.34%
YoY- -82.12%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 0 0 0 6 6,778 18 18 -
PBT -7,139 -6,718 -6,013 -5,945 -3,260 -16,024 -20,025 -15.78%
Tax -45 1 -335 -8 56 1 -4 49.66%
NP -7,094 -6,719 -6,013 -5,937 -3,260 -16,025 -20,021 -15.87%
Tax Rate - - - - - - - -
Total Cost 7,094 6,719 6,013 5,943 10,038 16,043 20,039 -15.88%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin 0.00 0.00 0.00 -98,950.00 -48.10 -89,027.78 -111,227.78 -
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.42 -0.46 -0.84 -2.47 -3.14 -18.49 -45.34 -54.15%
EPS Diluted -0.42 -0.46 -0.84 -2.47 -3.14 -18.49 -45.34 -54.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.